cancer therapeutic(Ono pharmaceuticals)

N/A

Report date: 2025/01/26 16:26:49
NME

Base Information

Drug Namecancer therapeutic(Ono pharmaceuticals)
Drug Alias NameDNA damage response programs (ONO Pharmaceuticals)cancer therapeutic(Ono pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKSQ Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOno Pharmaceutical Co Ltd
Inactive CompaniesKSQ Therapeutics Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A